- CSR Summary Not Yet Available
- NCT Number Not Available
- Primary Citation
- Data Specification Not Available
Trial Information
Generic NameGalantamineProduct NameRAZADYNE®Therapeutic AreaBehaviors and Mental DisordersEnrollment% FemaleN/A% WhiteN/A
Product ClassAlzheimer's Disease - Cholinesterase InhibitorsSponsor Protocol NumberGAL-MVD-302Data PartnerJohnson & JohnsonCondition StudiedAlzheimer DiseaseMean/Median Age (Years)N/A
Supporting Documentation
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available